(Q43995999)

28 November 2017

Prognostic relevance of c-Myc and BMI1 expression in patients with glioblastoma (English)

1 reference

28 November 2017

2

1 reference

28 November 2017

Tonia Cenci

1

1 reference

28 November 2017

Nicola Montano

3

1 reference

28 November 2017

Quintino G D'Alessandris

4

1 reference

28 November 2017

Maria Laura Falchetti

5

1 reference

28 November 2017

Daniela Annibali

6

1 reference

28 November 2017

Mauro Savino

7

1 reference

28 November 2017

Federico Bianchi

8

1 reference

28 November 2017

Francesco Pierconti

9

1 reference

28 November 2017

Sergio Nasi

10

1 reference

28 November 2017

Roberto Pallini

11

1 reference

28 November 2017

Luigi Maria Larocca

12

1 reference

American Journal of Clinical Pathology

28 November 2017

language of work or name

English

1 reference

inferred from

publication date

1 September 2012

1 reference

American Journal of Clinical Pathology

28 November 2017

1 reference

28 November 2017

138

1 reference

28 November 2017

3

1 reference

28 November 2017

390-396

1 reference

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

28 November 2017

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

c-Myc target genes involved in cell growth, apoptosis, and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Reflecting on 25 years with MYC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Transcription-independent functions of MYC: regulation of translation and DNA replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Analysis of Myc-induced histone modifications on target chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Transcription factors, chromatin and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Pediatric brain tumors: genetics and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

c-myc oncogene family expression in glioblastoma and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Stem cells and cancer; the polycomb connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Polycomb genes expression as a predictor of poor clinical outcome in children with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Bmi1 in development and tumorigenesis of the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Reduced c-Myc signaling triggers telomere-independent senescence by regulating Bmi-1 and p16(INK4a).

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Mel-18, a polycomb group protein, regulates cell proliferation and senescence via transcriptional repression of Bmi-1 and c-Myc oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

GSK3beta regulates differentiation and growth arrest in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

The WHO classification of tumors of the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Prognostic relevance of SOCS3 hypermethylation in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Expression of Ki-67, topoisomerase IIalpha and c-MYC in astrocytic tumors: correlation with the histopathological grade and proliferative status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Overexpression of multiple oncogenes related to histological grade of astrocytic glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Bcl-2 is a better therapeutic target than c-Myc, but attacking both could be a more effective treatment strategy for B-cell lymphoma with concurrent Bcl-2 and c-Myc overexpression

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

BMI1 sustains human glioblastoma multiforme stem cell renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

c-MYC expression sensitizes medulloblastoma cells to radio- and chemotherapy and has no impact on response in medulloblastoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Caspase-8, c-FLIP, and caspase-9 in c-Myc-induced apoptosis of fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

Temozolomide induced c-Myc-mediated apoptosis via Akt signalling in MGMT expressing glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

The action mechanism of the Myc inhibitor termed Omomyc may give clues on how to target Myc for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1309%2FAJCPRXHNJQLO09QA

21 January 2018

Identifiers

DOI

10.1309/AJCPRXHNJQLO09QA

1 reference

release_idle37fmmngz7kvqlzmaxmmdym

28 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/idle37fmmngz7kvqlzmaxmmdym

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference